Organization
University of Erlangen-Nürnberg Medical School
14 clinical trials
Clinical trial
Changes in Tissue Potassium Amount Before and After Treatment of Primary Hyperaldosteronism Assessed by 39K-MRIStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
First-line Treatment of Locally Advanced HNSCC With Double Checkpoint Blockade and Radiotherapy Dependent on Intratumoral CD8+ T Cell Infiltration (CheckRad-CD8, EudraCT NUMBER: 2017-003226-33)Status: Completed, Estimated PCD: 2021-09-16
Clinical trial
Effects of Finerenone on Renal Hemodynamics and Oxidative StressStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Register-Trial Based on an Agreement of Health Insurances With the Department of Radiation Therapy of the University Hospital Erlangen for the Application of Regional Hyperthermia in Bladder Cancer: Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With HyperthermiaStatus: Recruiting, Estimated PCD: 2098-12-31
Clinical trial
CAR-T Cells in Systemic B Cell Mediated Autoimmune DiseaseStatus: Recruiting, Estimated PCD: 2026-05-31
Clinical trial
Genetic Based Analysis of Identifying Predictors of Blood Pressure Response in Hypertensive Patients After Renal DenervationStatus: Active (not recruiting), Estimated PCD: 2020-07-23
Clinical trial
Phase I, Open-label, Fast-track Dose-escalation Clinical Trial Exploring the Safety and the Tolerability of Autologous ex Vivo Expanded Regulatory T Cells in Adults With Ulcerative ColitisStatus: Completed, Estimated PCD: 2023-04-12
Clinical trial
Randomized, Double-blind, Placebo Controlled, Parallel-group, Prospective Clinical Study to Analyse the Effect of Evolocumab on Vascular FunctionStatus: Completed, Estimated PCD: 2021-04-15
Clinical trial
A Randomised, Double-blind, Placebo-controlled, Phase III Trial to Study the Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With HypercholesterolemiaStatus: Completed, Estimated PCD: 2009-12-01
Clinical trial
Randomized Phase II Study of Immune Stimulation With Pembrolizumab and Radiotherapy in Second Line Therapy of Metastatic Head and Neck Squamous Cell Carcinoma (IMPORTANCE, Keynote-717, EudraCT NUMBER: 2017-002122-20 )Status: Recruiting, Estimated PCD: 2024-01-01
Clinical trial
Prospective, Randomized Controlled Trial to Investigate Additional Interventional Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (smartNTx)Status: Recruiting, Estimated PCD: 2025-04-30
Clinical trial
Significance of Chemoradiation Following Induction Chemotherapy in Locally Advanced,Unresectable Pancreatic Cancer -a Randomised Phase 3 Trial: Chemoradiation Following Induction Chemotherapy Compared With Chemotherapy AloneStatus: Completed, Estimated PCD: 2021-02-02
Clinical trial
Randomized, Double-blind, Placebo Controlled, Parallel Group, Prospective Clinical Study to Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 DiabetesStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Investigation of the Timely-coordinated Therapy of Patients With Metastatic Cancer by Radiotherapy Together With Immune Checkpoint InhibitionStatus: Completed, Estimated PCD: 2021-02-28